相关实验视频
Updated: Jul 12, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
在甲状腺癌中,PRMT1通过上调ZEB1/H4R3me2as来加速细胞增殖,迁移和瘤生长
Guoli Feng1, Changju Chen2, Yi Luo1
1Department of General Surgery, Department of Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
Oncology reports
|October 20, 2023
概括
蛋白质氨酸甲基转移酶1 (PRMT1) 促进甲状腺癌 (TC) 的生长和转移. 抑制PRMT1抑制了瘤的进展和转移,这表明PRMT1是TC的治疗标.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 甲状腺癌 (TC) 是最常见的内分泌恶性瘤.
- 蛋白质氨酸甲基转移酶1 (PRMT1) 在各种生物过程中发挥作用.
研究的目的:
- 研究PRMT1在甲状腺癌进展中的作用和机制.
主要方法:
- 利用了人类TC细胞系和小鼠模型.
- 通过敲击和过度表达操纵PRMT1表达.
- 评估细胞增殖,细胞亡,迁移以及蛋白质/mRNA水平.
主要成果:
- 在TC组织中,PRMT1表达升高.
- PRMT1的敲击抑制了TC细胞的增殖,迁移和转移.
- 降低PRMT1的调节增加了E-cadherin,并降低了维丁,H4R3me2as和ZEB1.
- 过度表达PRMT1显示出相反的效果.
结论:
- 通过对H4R3me2as/ZEB1.1.进行上调,PRMT1促进TC恶性瘤.
- PRMT1代表了TC的潜在治疗标和诊断标记物.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K

